HOUGH EAR INST has a total of 48 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are PDS BIOTECHNOLOGY CORP, NATURE TECHNOLOGY INC and SOUND PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 8 | |
#5 | Canada | 7 | |
#6 | Japan | 3 | |
#7 | China | 2 | |
#8 | Israel | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Electrotherapy | |
#5 | Peptides | |
#6 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Kopke Richard D | 30 |
#2 | Floyd Robert A | 15 |
#3 | Towner Rheal | 7 |
#4 | Kopke Richard Dana | 7 |
#5 | Hough Jack V D | 6 |
#6 | Li Wei | 5 |
#7 | West Matthew B | 5 |
#8 | Dyer R Kent Jr | 4 |
#9 | Robert A Floyd | 2 |
#10 | Dyer Jr R Kent | 2 |
Publication | Filing date | Title |
---|---|---|
AU2019339352A1 | Methods for treating hearing loss incident to cochlear implant surgery | |
EP3787750A1 | Methods for reducing accumulated pathologic tau protein | |
CN110248650A | Method for enhancing cynapse generation and neural process generation | |
CN109562140A | For inner ear sensory hair cell regeneration/replacement conjoint therapy | |
CA2826602A1 | Methods for treating brain injury | |
AU2011261364A1 | Composition and method for inner ear sensory hair cell regeneration and replacement | |
EP2470015A1 | Nitrone compounds for treating sensorineural hearing loss | |
AU2007277193A1 | Methods for treating acute acoustic trauma | |
EP1631259A1 | Otologic nanotechnology |